News
News
Services do NOT include
Extended immunology or molecular assays or bioinformatic analyses are not included, but can be offered.
Possible Output
Study plan, animal experiment approval by the institutional AWB and the Dutch Central Authority for Scientific Procedures on Animals (CCD), raw data as excel file and a summarizing report on the study, biological samples.
Sample Requirements - input of users
Well described vaccine formulations and/or SOP for vaccine formulation; user is responsible for transport of vaccines.
Lead Scientist
Dr. Norbert Stockhofe-Zurwieden, DVM, Spec. Vet. Pathol.
Immunogenicity, challenge and efficacy studies in pigs, ruminants and other farm animals - SWR
Description of service
As partner of TRANSVAC2, WBVR will provide access to their animal facilities (Lelystad) to carry out immunogenicity and efficacy studies of new candidate vaccines and/or of novel vaccination (administration) strategies in pigs, cattle, ferrets or other animal species. Efficacy studies depend on the availability of the challenge model and can be performed in biosafety containment up to BSL3. The access will comprise purchase of animals, the housing and animal care and biotechnical expertise for administration and sampling. Scientific support will include advice on experimental design and methodology, documentation of results for all experiments conducted during the project, and appropriate sampling and conservation of samples. Laboratory analyses are included to primary read-outs like haematology, immunology, pathology, but need to be defined on a case by case evaluation. WBVR will also provide the required legal approvals and ethical approval.
Timeline
Depending on the type of animal study*
*4 months (min) , if approval by the Dutch Central Authority for Scientific Procedures on Animals (CCD); 2 months, after end of the in-life phase for analysis and reporting.
Cost coverage opportunities
If you are interested in this service please contact the service provider directly
Currently not available